Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP4OX in trauma patients with lactic acidosis due to hemorrhagic shock
2009-013115-35Phase 2Completed
- Sponsor
- Sangart
- Start
- Sep 2009
- Modality
- Albumin → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lactic acidosis comparing MP4OX plus standard of care with Ringer's lactate plus standard of care (2 arms). Primary endpoint: 2-hour lactate clearance. Started Sep 2009; status: completed.
02
Drugs
Hemospan
03
Conditions
lactic acidosis
Beyond the preview
Go deeper on 2009-013115-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013115-35.